Track: Pediatric and Congenital Cardiology
Advances in paediatric cardiac surgery and transcatheter intervention have dramatically transformed congenital heart disease from a condition with near-universal childhood mortality to one where the majority of patients survive into adulthood creating a growing population of adults with congenital heart disease (ACHD) who require lifelong specialist follow-up. The Congenital Heart Disease & Paediatric Cardiology session examines transcatheter pulmonary valve replacement, catheter-based closure of complex septal defects and patent ductus arteriosus, foetal cardiac intervention, the unique cardiovascular risk profile and arrhythmia burden in ACHD, heart failure management in univentricular circulation, and the application of AI and 3D printing in congenital cardiac anatomy planning.
Key Discussion Areas:
- Transcatheter pulmonary valve replacement: MELODY and SAPIEN outcomes
- Catheter-based closure of ASD, VSD, and PDA in complex anatomy
- Adults with congenital heart disease (ACHD): long-term management and surveillance
- Foetal cardiology: diagnosis, counselling, and in-utero intervention
- Heart failure and Fontan circulation: management and transplant considerations
- Arrhythmia management in congenital heart disease
- AI and 3D-printed cardiac models in CHD planning and simulation
- Pregnancy and contraception counselling in adults with congenital heart disease
Why Attend This Session?
Paediatric cardiologists, ACHD specialists, congenital cardiac surgeons, and echocardiographers will gain essential updates on transcatheter intervention techniques, ACHD surveillance protocols, and the multidisciplinary management of complex lifelong cardiovascular conditions across the age spectrum.
Related Topics:
- Cardiac Genetics & Inherited Cardiovascular Disorders
- Cardiac Imaging & Advanced Diagnostics
- Electrophysiology & Arrhythmia Management
- Women's Heart Health
- Cardiovascular Surgery
Frequently Asked Questions:
1.What is the current life expectancy for adults living with congenital heart disease?
The majority of patients with simple to moderate CHD now survive to adulthood with near-normal life expectancy following successful surgical or transcatheter correction. Complex CHD including single-ventricle and cyanotic conditions carries ongoing mortality risk, heart failure burden, and arrhythmia complications requiring lifelong specialist ACHD centre follow-up.
2.How is transcatheter pulmonary valve replacement changing management of repaired tetralogy of Fallot?
Transcatheter pulmonary valve replacement (TPVR) using MELODY or SAPIEN valves allows correction of pulmonary regurgitation following repaired tetralogy of Fallot without repeat open surgery, significantly reducing RV dilation and improving functional capacity — and is increasingly used in native and surgically enlarged RVOT anatomy.
Scientific Highlights
- Preventive Cardiology and Cardiovascular Risk Reduction
- Heart Failure and Advanced Cardiac Therapies
- Interventional Cardiology and Structural Heart Disease
- Cardiac Electrophysiology and Arrhythmia Management
- Acute Coronary Syndromes
- Cardiovascular Imaging and Multimodality Diagnostics
- Cardiomyopathies: Genetics, Phenotyping, and Treatment
- Cardio Oncology
- Cardiometabolic Disease, Lipidology, and Atherosclerosis
- Hypertension and Renal Cardiovascular Interactions
- Digital Health, AI, and the Future of Cardiology
- Pediatric and Congenital Cardiology
- Vascular Medicine and Aortic Diseases
- Women's Cardiovascular Health and Sports Cardiology
- Precision Medicine, Genomics, and Regenerative Cardiology
- Cardiovascular and Cardiothoracic Surgery
- Cardiovascular Case Studies and Clinical Insights
- Emergency and Critical Cardiac Care